Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.
Level 5 - mechanism / opinion, no new human data
Narrative review describing mechanistic pathology without new human trial or cohort data.
PubMed 26662475 · doi:10.1111/nan.12298
What was done
This narrative review synthesizes pathological and experimental evidence regarding the formation, regional distribution, and trans-synaptic propagation of alpha-synuclein aggregates across the enteric, peripheral, and central nervous systems in sporadic Parkinson's disease.
What was found
No empirical numbers or statistical metrics are reported in the abstract. The review describes alpha-synuclein aggregation as a non-remitting process likely initiating at environmentally exposed sites (olfactory bulb and enteric nervous system) and progressing retrogradely to the dorsal motor nucleus of the vagal nerve. From the lower brainstem, pathology is described as advancing caudo-rostrally through brainstem centers to the midbrain, forebrain, and cerebral cortex, alongside descending and sympathetic involvement of spinal cord centers.
Why it matters
It outlines the anatomical framework for stereotypic alpha-synuclein transmission across interconnected neuronal networks, highlighting potential pathways for disease-modifying therapeutic strategies.
Limits
The abstract reports no primary sample sizes, statistical data, or systematic search methodology. The described progression relies on mechanistic models and preclinical research, which may not capture all heterogeneous or non-stereotypic trajectories of sporadic Parkinson's disease.
Cited by
- supports In 2003, Dr. Heiko Braak proposed that misfolded protein pathology in Parkinson's disease propagates progressively from nerve cell to nerve cell.